Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 2, 2009, 5:33PM ET - U.S. Markets Closed. Dow  0.18% Nasdaq  0.42%

Peregrine Pharmaceuticals Inc. (PPHM)

At 4:00PM ET: 2.83   0.21 (8.02%)

MORE ON PPHM

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Wed, Dec 2, 2009 • InPlay: Peregrine Pharma completes patient enrollment in Cotara dose confirmation and dosimetry brain cancer trial Briefing.com (Wed 9:30am) • Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial PR Newswire (Wed 9:30am) Thu, Nov 19, 2009 • PEREGRINE PHARMACEUTICALS INC Financials EDGAR Online Financials (Thu, Nov 19) Wed, Nov 18, 2009 • Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference PR Newswire (Wed, Nov 18) Tue, Nov 10, 2009 • UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector Wall Street Transcript (Tue, Nov 10) • New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's Bavituximab With Radiation in a Lethal Brain Cancer Model PR Newswire (Tue, Nov 10) Wed, Nov 4, 2009 • Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies PR Newswire (Wed, Nov 4) Tue, Nov 3, 2009 • Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements PR Newswire (Tue, Nov 3) Wed, Oct 28, 2009 • Biotech Sector Pullback: Good Time to Buy at a Discount at Seeking Alpha (Wed, Oct 28) Tue, Oct 27, 2009 • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online (Tue, Oct 27) • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online (Tue, Oct 27) Mon, Oct 26, 2009 • Trading Outlook for Peregrine Pharmaceuticals Issued by StockPreacher.com GlobeNewswire (Mon, Oct 26) Thu, Oct 22, 2009 • PEREGRINE PHARMACEUTICALS INC Financials EDGAR Online Financials (Thu, Oct 22) Wed, Oct 21, 2009 • Peregrine drug prompts response in cancer study AP (Wed, Oct 21) • Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer PR Newswire (Wed, Oct 21) Tue, Oct 20, 2009 • Peregrine: Continuing to Accumulate on Any Dips at Seeking Alpha (Tue, Oct 20) Mon, Oct 19, 2009 • Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs PR Newswire (Mon, Oct 19) • Peregrine Pharmaceuticals 1:5 Reverse Stock Split Takes Effect PR Newswire (Mon, Oct 19) • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi EDGAR Online (Mon, Oct 19) • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi EDGAR Online (Mon, Oct 19) Older Headlines - Download Recent Headlines View headlines from: Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009Mon, Sep 7, 2009Mon, Aug 31, 2009Mon, Aug 24, 2009Mon, Aug 17, 2009 Add PPHM News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage